|
|
|
Volumn 3, Issue 2, 2011, Pages 716-723
|
|
Denovo design and optimization of novel inhibitor molecules for HIV integrase
a
|
|
Author keywords
Denovo; Docking; Insilico; Integrase
|
|
Indexed keywords
1,1' [2 [( 3,4 DIHYDROPYRIMIDO[4,5 D]PYRIMIDIN 4 YLOXY)METHYL] HYDRAZINE 1,1 DIYL]DIBUTAN 2 ONE;
1,1' [PTERIDINE 2,7 DIYLBIS(OXY)]BIS(3 HYDROXYPROPAN 2 ONE);
2 [7 ACETYL 4 (IMIDAZOLIDIN 4 YLMETHYL)PYRIMIDO[4,5 D]PYRIMIDIN 2 YL]ACETAMIDE;
4 (3,4 DIHYDROXYBENZYL) 7 (HYDROXYMETHYL) N,N DIMETHYLPYRIMIDO[4,5 D]PYRIMIDINE 2 CARBOXAMIDE;
4 [(2 ACETYLHYDRAZINYL)METHYL] 3,4 DIHYDROPYRIMIDO[4,5 D]PYRIMIDIN 2 YL PROPANOATE;
7 (HYDROXYACETYL) N,N DIMETHYL 4 (1,3 OXAZOL 4 YLMETHYL)PYRIMIDO[4,5 D]PYRIMIDINE 2 CARBOXAMIDE;
7 (HYDROXYACETYL) N,N DIMETHYL 4 (1,3 THIAZOLIDIN 4 YLMETHYL)PYRIMIDO[4,5 D]PYRIMIDINE 2 CARBOXAMIDE;
7 (HYDROXYACETYL) N,N DIMETHYL 4 (PYRIDIN 3 YLMETHYL)PYRIMIDO[4,5 D]PYRIMIDINE 2 CARBOXAMIDE;
7 (HYDROXYACETYL) N,N DIMETHYL 4 (PYRIMIDIN 5 YLMETHYL)PYRIMIDO[4,5 D]PYRIMIDINE 2 CARBOXAMIDE;
7 ACETYL N,N DIMETHYL 4 (4H PYRAZOL 4 YL)PYRIMIDO[4,5 D]PYRIMIDINE 2 CARBOXAMIDE;
INTEGRASE;
INTEGRASE INHIBITOR;
LIGAND;
UNCLASSIFIED DRUG;
VIRUS DNA;
ARTICLE;
BINDING AFFINITY;
BIOAVAILABILITY;
BIOSAFETY;
DRUG STRUCTURE;
DRUG TARGETING;
ENZYME INHIBITION;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYDROGEN BOND;
MOLECULAR DOCKING;
NONHUMAN;
PHARMACOPHORE;
|
|
EID: 79955822163
PISSN: None
EISSN: 09744290
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (20)
|
